A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/14/1997	US5677283 Antiinflammatory agents, nervous system disorders
10/14/1997	US5677282 Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase
10/14/1997	US5677281 Use of peptide derivatives for the preparation of medicaments inhibiting endopeptidases 24.15 and 24.16
10/14/1997	US5677280 Peptides and compounds that bind to the IL-5 receptor
10/14/1997	US5677279 Methods and compositions for treating pain with amylin or agonists thereof
10/14/1997	US5677278 Truncated keratinocyte growth factor (KGF) having increased biological activity
10/14/1997	US5677277 Brain disorders
10/14/1997	US5677276 Wound healing and tissue regeneration
10/14/1997	US5677275 Treatment of cancer with human chorionic gonadotropin
10/14/1997	US5677274 Anthrax toxin fusion proteins and related methods
10/14/1997	US5677184 Genetic engineered chinese hamster ovary cells
10/14/1997	US5677182 Cleavage site blocking antibody to prohormone proteins and uses thereof
10/14/1997	US5677181 Antitumor, antiinflammatory agents
10/14/1997	US5677180 Chimeric antibody with specificity to human B cell surface antigen
10/14/1997	US5677177 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
10/14/1997	US5677176 Animal derived cell with antigenic protein introduced therein
10/14/1997	US5677171 Inhibit growth of sk-br-3 breast tumor cells
10/14/1997	US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation
10/14/1997	US5677162 Cold incubation
10/14/1997	US5677149 Culturing under suitable conditions a host cell transformed or trasnfected with a replicable vector comprising specific nucleic acid sequence in a manner allowing expression of the polypeptide and recovering transformed polypeptide
10/14/1997	US5677148 Genetic engineering
10/14/1997	US5677147 HIV-2 virus variants
10/14/1997	US5677146 Human amyloid protein precursor homolog and kunitz-type inhibitor
10/14/1997	US5677144 Genetic engineered vectors expressing a polypeptide
10/14/1997	US5677143 Isolated nucleic acid encoding amino acid sequence of cellular protein
10/14/1997	US5677135 Method for increasing the resistance of neural cells to βamyloid peptide toxicity
10/14/1997	US5677132 Using antibody; immunoassay of psychoactive drug
10/14/1997	US5676978 Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
10/14/1997	US5676974 Pharmaceutical compositions containing giroxina and phospholipase A2 and methods of increasing a patient's CD4 count using the pharmaceutical compositions
10/14/1997	US5676973 Synergistic effect treating skin disorder
10/14/1997	US5676971 Agents for inhibiting adsorption of proteins on the liposome surface
10/14/1997	US5676953 Intestinal protozoal vaccines
10/14/1997	US5676951 Bovine herpesvirus type 1 deletion mutants and vaccines
10/14/1997	US5676947 Method for treating thromboembolic conditions using thrombolytically active proteins
10/14/1997	US5676946 Phospholipase C homolog
10/14/1997	US5676944 Ocular therapy with homologous macrophages
10/14/1997	US5676943 Nerve growth factor
10/14/1997	US5676942 Composition containing human alpha interferon species proteins and method for use thereof
10/14/1997	US5676941 Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor
10/14/1997	US5676940 Method of reducing immunoglobulin E responses
10/14/1997	US5676931 Aerosol drug formulations for use with non CFC propellants
10/13/1997	CA2178132A1 Isolation of novel peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
10/09/1997	WO1997037230A1 Tfiib transcription factor from candida albicans
10/09/1997	WO1997037228A1 Methods for diagnosing and treating alzheimer's disease
10/09/1997	WO1997037225A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+-DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF
10/09/1997	WO1997037224A1 Protein phosphatase-1 catalytic subunit interactions
10/09/1997	WO1997037223A1 Identification and isolation of novel polypeptides having ww domains and methods of using same
10/09/1997	WO1997037044A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
10/09/1997	WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein
10/09/1997	WO1997037029A1 MONOCLONAL ANTIBODIES SPECIFIC FOR THE PLATELET DERIVED GROWTH FACTOR β RECEPTOR AND METHODS OF USE THEREOF
10/09/1997	WO1997037027A1 Novel cyclin-selective ubiquitin carrier polypeptides
10/09/1997	WO1997037026A1 Novel compounds
10/09/1997	WO1997037022A1 Human natural killer cell activating factor ii
10/09/1997	WO1997037021A1 Human cystatin f
10/09/1997	WO1997037020A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	WO1997037019A1 Cell proliferation inhibitor
10/09/1997	WO1997037018A1 Novel gene
10/09/1997	WO1997037017A1 Cytostatic factors
10/09/1997	WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use
10/09/1997	WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/09/1997	WO1997037014A1 Genetic suppression and replacement
10/09/1997	WO1997037013A1 Asymmetric hammerhead ribozymes
10/09/1997	WO1997037010A1 Active survival domains of igf-ir and methods of use
10/09/1997	WO1997037005A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	WO1997037003A1 Laminin 5 for growth of pancreatic islet cells
10/09/1997	WO1997037002A1 Promotion of regeneration of organized tissues
10/09/1997	WO1997037001A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
10/09/1997	WO1997036932A1 Modified/chimeric superantigens and their use
10/09/1997	WO1997036927A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	WO1997036926A1 Growth differentiation factor-14
10/09/1997	WO1997036925A1 Candida albicans tata-binding protein, nucleic acid and assays
10/09/1997	WO1997036923A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
10/09/1997	WO1997036922A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997	WO1997036921A1 Antifungal peptides from scleroderma texense
10/09/1997	WO1997036919A2 Cytokine designated lerk-8
10/09/1997	WO1997036915A1 Human cystatin f
10/09/1997	WO1997036914A1 High molecular weight surface proteins of non-typeable haemophilus
10/09/1997	WO1997036874A1 Eprosartan dihydrate and a process for its production and formulation
10/09/1997	WO1997036873A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
10/09/1997	WO1997036869A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/09/1997	WO1997036615A1 Regulation of vascular smooth muscle cell heme oxygenase-1
10/09/1997	WO1997036614A1 Polymerized staphylococcal protein a for treatment of diseases
10/09/1997	WO1997036612A1 Anti-cryptosporidium parvum preparations
10/09/1997	WO1997036611A1 Cyclosporin emulsions
10/09/1997	WO1997036610A1 Cyclosporin-containing pharmaceutical composition
10/09/1997	WO1997036609A2 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
10/09/1997	WO1997036608A1 CONTROL OF CANCER GROWTH THROUGH THE INTERACTION OF [MET5]-ENKEPHALIN AND THE ZETA (z) RECEPTOR
10/09/1997	WO1997036606A1 Constrained cd4 peptides and methods of using the same
10/09/1997	WO1997036602A1 Method of restoring a functional protein in a tissue by cell transplantation
10/09/1997	WO1997036601A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	WO1997036587A1 A method of treating cancer
10/09/1997	WO1997036547A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
10/09/1997	WO1997036495A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/09/1997	WO1997036481A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/09/1997	WO1997036480A1 Compounds and compositions for delivering active agents
10/09/1997	WO1997036477A1 Transgenic model of heart failure
10/09/1997	WO1997032022A3 Canine ob protein compositions and methods
10/09/1997	WO1997032018A3 Hepatitis c virus ribozymes
10/09/1997	WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof
10/09/1997	WO1997030156A3 Nucleotides and peptides corresponding to the canine ige heavy chain constant region and related methods

1 ... 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 ... 3163